Transcarent Stock
Transcarent is a health technology company that aims to simplify access to high-quality, affordable healthcare for individuals and organizations. Founded to address the complexities of the healthcare system, Transcarent provides a comprehensive platform that combines benefits navigation, clinical guidance, and care delivery.
Sign up for SecondMarket™ to view the market and buy or sell Transcarent Stock
Buy + SellTranscarent Funding
Sign up to gain insights into Transcarent funding history, including the funding round, time period, and amount raised.
Sign Up to Unlock the DataDate | Financing Round | Amount | Price per share* | Valuation* |
---|---|---|---|---|
Mar 07, 2024 | Series D | 125.80M | ||
Jan 27, 2022 | Series C | 8.75M | ||
Jan 11, 2022 | Series C | 200.00M | ||
Jun 10, 2021 | Series B | 58.00M | ||
Nov 19, 2020 | Series A | 46.40M | ||
Jun 17, 2020 | Series Seed | 3.37M |
See Transcarent Valuations + Financials
*Sample data + company shown for illustrative purposes only
Gain insights Into Transcarent Stock Valuation + Share Prices
View real-time Tape D™ data on Transcarent stock including most recent valuation and historical share price information.
Are you an institutional investor or employee shareholder? Sign up to the SecondMarket™ trading platform.
Get StartedTranscarent Management Team
Chief Strategy Officer
Caitlin Fleming
Chief Financial Officer
Stephanie Peng
Chief Medical Officer
Randy Hawkins
Chief Technology Officer
Praful Kaul
Chief Operating Officer
Snezana Mahon
CEO, Director
Glen Tullman
Chief Innovation Officer
Jeff Dobro
Chief Marketing Officer
Janine Gianfredi
Director
David Calone
Director
Peter Hudson
Director
Lee Shapiro